Picture of Jeonjin Bio Co logo

110020 Jeonjin Bio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,462-3,418-2,108-3,154-6,440
Depreciation
Amortisation
Non-Cash Items30.51,640-6291575,282
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-293-972-14.3-2,105-979
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,299-2,310-2,385-3,710-301
Capital Expenditures-722-5,837-1,933-2,129-672
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-77.80.8275-2,177638
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-800-5,836-1,858-4,306-33.5
Financing Cash Flow Items-172-196-30.9-726-689
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities92412,90910,629-5,928694
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,1704,7606,383-13,971358